Conclusion: The collective findings from these trials showed an effective management of CINV using ondansetron. Conclusion: Through a comprehensive overview of clinical trials, the use of ondansetron in adult cancer patients represents a significant improvement in CINV management.
PubMed 38074143 ↗Zofran
The short answer. There isn't much data on Zofran yet — 4 mentions, 2 with a clear outcome — so treat these numbers as anecdotal. There is a moderate body of research — 1 meta-analyses and 20 trials.
From 4 mentions in total — the rest didn't say how it went and aren't counted.
What Zofran does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Happy I took zofran prior or I'd definitely been puking”
More medications
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate